Pharmacogenmics, or PGx, is the study of how variations in the human genome dictate a persons response to medication
Learn moreFindings from PGx research can lead to better treatment outcomes for both individuals and healthcare providers.
PGx: an important step towards personalised healthcare
Signigene aims to deliver on Pharmacogenomics for Insurance companies to make a big push to integrate personalised medicine in the holistic healthcare system.
Our solution for insurance platforms offers a personalised treatment advice based on current guidelines for the use of genetic biomarkers, the best solution on a patient by patient basis without disclosing genetic information. This way we can help to reduce liability risk for insurance platforms within their business activity without having to access sensitive information directly.
Moreemail info@signigene.com
Scan this code with an authenticator app, such as Authy or Google Authenticator, preferably on a different device, then type in the access code it shows below and click OK to check it has been set up correctly. Then save your profile and then when you sign in you will be prompted for an access code, open your authenticator to get the current value and type it in.
Page: index